TheraRadar
← Back
Data updated: Mar 29, 2026

NORVIUM BIOSCIENCE

Pharmaceuticals
Specialty

NORVIUM BIOSCIENCE is a specialty pharmaceutical company with 5 FDA-approved products.

1958
Since
5
Drugs
-
Trials
22
Approved (2yr)

Key Drugs

No active drugs

Top Drug Revenues Pro

Loading...

Revenue Over Time Pro

Loading...

Recent Activity

SUMATRIPTAN SUCCINATE 2025-11-06
SUMATRIPTAN SUCCINATE 2025-10-21
Labeling
TRIAMCINOLONE ACETONIDE 2025-10-17
TRIAMCINOLONE ACETONIDE 2025-10-08
Labeling
SUMATRIPTAN SUCCINATE 2025-07-25
Labeling
SUMATRIPTAN SUCCINATE 2025-07-15
TRIAMCINOLONE ACETONIDE 2025-04-11
TRIAMCINOLONE ACETONIDE 2025-04-03
Labeling
SEC Filings Pro
Loading...

Therapeutic Areas

Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5

No indication data

Pipeline Forecast

Loading...

Upcoming Trial Milestones Pro

Loading...

Patent Cliff Pro

Loading...